FI118472B - Autoantigeenistä johdettuja uusia peptidejä autoimmuunitautien immunoterapiassa käyttöä varten - Google Patents

Autoantigeenistä johdettuja uusia peptidejä autoimmuunitautien immunoterapiassa käyttöä varten Download PDF

Info

Publication number
FI118472B
FI118472B FI962619A FI962619A FI118472B FI 118472 B FI118472 B FI 118472B FI 962619 A FI962619 A FI 962619A FI 962619 A FI962619 A FI 962619A FI 118472 B FI118472 B FI 118472B
Authority
FI
Finland
Prior art keywords
seq
peptides
peptide
amino acid
cells
Prior art date
Application number
FI962619A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962619A0 (fi
FI962619A (fi
Inventor
Anna Maria Helena Boots
Gijsbertus Francisc Verheijden
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of FI962619A0 publication Critical patent/FI962619A0/fi
Publication of FI962619A publication Critical patent/FI962619A/fi
Application granted granted Critical
Publication of FI118472B publication Critical patent/FI118472B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI962619A 1994-10-27 1996-06-25 Autoantigeenistä johdettuja uusia peptidejä autoimmuunitautien immunoterapiassa käyttöä varten FI118472B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP94203128 1994-10-27
EP94203128 1994-10-27
EP95200886 1995-04-07
EP95200886 1995-04-07
EP9504201 1995-10-25
PCT/EP1995/004201 WO1996013517A1 (en) 1994-10-27 1995-10-25 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases

Publications (3)

Publication Number Publication Date
FI962619A0 FI962619A0 (fi) 1996-06-25
FI962619A FI962619A (fi) 1996-06-25
FI118472B true FI118472B (fi) 2007-11-30

Family

ID=26136688

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962619A FI118472B (fi) 1994-10-27 1996-06-25 Autoantigeenistä johdettuja uusia peptidejä autoimmuunitautien immunoterapiassa käyttöä varten

Country Status (24)

Country Link
US (1) US5736507A (es)
EP (1) EP0733065B1 (es)
JP (1) JP3755894B2 (es)
KR (1) KR100485979B1 (es)
CN (1) CN1161379C (es)
AT (1) ATE177756T1 (es)
AU (1) AU696827B2 (es)
BR (1) BR9506377A (es)
CA (1) CA2173874A1 (es)
DE (1) DE69508380T2 (es)
DK (1) DK0733065T3 (es)
ES (1) ES2130672T3 (es)
FI (1) FI118472B (es)
GR (1) GR3030296T3 (es)
HK (1) HK1002012A1 (es)
HU (1) HU218027B (es)
IL (1) IL115744A (es)
MX (1) MX9602495A (es)
NO (1) NO316703B1 (es)
NZ (1) NZ295659A (es)
PL (1) PL183761B1 (es)
RU (1) RU2178797C2 (es)
TR (1) TR199501326A2 (es)
WO (1) WO1996013517A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843449A (en) * 1996-03-25 1998-12-01 Akzo Nobel N.V. Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
US6881824B1 (en) 1996-04-24 2005-04-19 Akzo Nobel N.V. Peptides suitable for use in antigen specific immunosuppressive therapy
IL120561A0 (en) * 1996-04-24 1997-07-13 Akzo Nobel Nv Peptides suitable for use in immunosuppressive therapy
EP0947524A1 (en) * 1998-03-30 1999-10-06 Upither B.V. Novel peptides for the treatment of autoimmune diseases
CN1310724A (zh) * 1998-07-23 2001-08-29 阿克佐诺贝尔公司 用于自身免疫疾病的免疫疗法中的新型肽
WO2000004917A2 (en) * 1998-07-23 2000-02-03 Akzo Nobel N.V. USE OF HC gp-39 IN IMMUNE DISEASES
MXPA02003520A (es) * 1999-10-18 2002-08-20 Akzo Nobel Nv Imitaciones de peptido y peptidos modificados para utilizarse en inmunoterapia.
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
WO2003009808A2 (en) 2001-07-24 2003-02-06 Yale University Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
EP1729805A4 (en) * 2004-02-25 2008-11-26 Medimmune Inc METHODS AND COMPOSITIONS RELATED TO CHITINASES AND CHITINASE-MOLECULARS AND MODULATION OF OSTEOCLASTS
WO2007027748A2 (en) * 2005-08-31 2007-03-08 Medimmune, Inc. C/clp antagonists and methods of use thereof
RU2302872C9 (ru) * 2006-06-22 2008-12-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Средство, нормализующее функции хрящевой ткани, и способ его получения
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
DK2190473T3 (da) 2007-08-15 2013-03-25 Circassia Ltd Peptid med reduceret dimerdannelse
WO2010018384A1 (en) * 2008-08-15 2010-02-18 Circassia Limited T-cell antigen peptide from allergen for stimulation of il-10 production
PT2153841E (pt) 2008-08-15 2012-03-21 Circassia Ltd Vacina compreendendo péptidos amb a 1 para utilização no tratamento de alergia a ambrósia
US8753644B2 (en) 2009-02-05 2014-06-17 Circassia Limited Grass peptides for vaccine
HUE029150T2 (hu) * 2009-10-27 2017-02-28 Erytech Pharma Készítmény specifikus immuntolerancia indukálására
WO2017041051A1 (en) 2015-09-04 2017-03-09 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6323898A (ja) * 1986-07-16 1988-02-01 Dainippon Pharmaceut Co Ltd 新規ポリペプチド及びそれをコ−ドするｄｎａ並びにそれらの製法
IL92629A0 (en) * 1989-12-10 1990-08-31 Yeda Res & Dev Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices

Also Published As

Publication number Publication date
KR100485979B1 (ko) 2006-01-27
DE69508380D1 (de) 1999-04-22
PL183761B1 (pl) 2002-07-31
CN1168677A (zh) 1997-12-24
GR3030296T3 (en) 1999-09-30
HK1002012A1 (en) 1998-07-24
NO962695L (no) 1996-06-26
ES2130672T3 (es) 1999-07-01
FI962619A0 (fi) 1996-06-25
AU696827B2 (en) 1998-09-17
HU9601401D0 (en) 1996-07-29
HUT74847A (en) 1997-02-28
IL115744A0 (en) 1996-01-19
JPH09507861A (ja) 1997-08-12
KR960705848A (ko) 1996-11-08
WO1996013517A1 (en) 1996-05-09
CA2173874A1 (en) 1996-05-09
DE69508380T2 (de) 1999-09-09
EP0733065A1 (en) 1996-09-25
RU2178797C2 (ru) 2002-01-27
NO316703B1 (no) 2004-04-13
TR199501326A2 (tr) 1996-06-21
IL115744A (en) 2000-07-16
AU3925295A (en) 1996-05-23
EP0733065B1 (en) 1999-03-17
NO962695D0 (no) 1996-06-26
MX9602495A (es) 1997-05-31
PL315198A1 (en) 1996-10-14
ATE177756T1 (de) 1999-04-15
US5736507A (en) 1998-04-07
JP3755894B2 (ja) 2006-03-15
HU218027B (hu) 2000-05-28
NZ295659A (en) 1998-02-26
DK0733065T3 (da) 1999-10-11
FI962619A (fi) 1996-06-25
BR9506377A (pt) 1997-09-16
CN1161379C (zh) 2004-08-11

Similar Documents

Publication Publication Date Title
FI118472B (fi) Autoantigeenistä johdettuja uusia peptidejä autoimmuunitautien immunoterapiassa käyttöä varten
US5843449A (en) Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
Gairin et al. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes
Goyert et al. Isolation of I–A subregion-like molecules from subhuman primates and man
JP4794102B2 (ja) フィブリンのシトルリン誘導体及び慢性関節リウマチの診断又は治療のためのその使用
RU2199548C2 (ru) Новые пептиды, которые могут быть использованы в антиген-специфической иммуносупрессорной терапии
Krco et al. Characterization of the antigenic structure of human type II collagen.
KR100769338B1 (ko) 류마티스성 관절염（ｒａ） 항원성 펩타이드
CA2187299A1 (en) Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
IE74168B1 (en) Genes coding for a protein having human MACIF activity expression vectors containing said genes transformant cells and proteins having human MACIF activity
JP5999703B2 (ja) ＨＬＡ−ＤＲ１拘束性Ｔａｘ特異的ＣＤ４＋Ｔ細胞エピトープ
Rees et al. The effect of lipoylation on CD4 T-cell recognition of the 19,000 MW Mycobacterium tuberculosis antigen.
AU704942B2 (en) Novel peptides for use in treatment of T-cell mediated cartilage destruction in autoimmune diseases
AU1906592A (en) Peptides for use in induction of t cell activation against hiv-1
US20040022777A1 (en) Fragments and antagonists of heat shock protein 60
KR20010071020A (ko) 자가 면역 질환의 면역 요법에서 사용하기 위한 신규한펩티드
US20020177554A1 (en) Novel peptides for use in treatment of T-cell mediated cartilage destruction in autoimmune diseases
MXPA98008866A (es) Novedosos peptidos adecuados para usarse en terapia inmunosupresora especifica de antigeno

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: N.V. ORGANON

Free format text: N.V. ORGANON

FG Patent granted

Ref document number: 118472

Country of ref document: FI